All News

Biosimilars are the future of pharmacy. When they hit community pharmacy, issues that have been important in specialty settings are going to explode.

McKesson recognized some outstanding community pharmacies at this year's IdeaShare.

Pharmacists on P&T committees are going to face issues that range from biosimilar naming systems to challenges in dispensing and costs.

Anticoagulation briefs.

Brivaracetam provides another adjunctive treatment option for partial onset seizures in patients with uncontrolled epilepsy.

What is the pharmacist’s duty? This case history may shed some light.

FDA has stated that it intends to continue inspections of compounding pharmacies, and it has taken aggressive action, including enforcement actions, as appropriate to protect the public health.

Once physicians see what you can do for them, they won't want to let you go.

In 2004, Rhode Island became the first state to authorize its pharmacy board to license Canadian pharmacies to ship medications to its residents.

Continuous medication management pays off.

And Medicare, Medicaid, and private insurers are increasingly willing to pay.

Local HIE, regional EHR, interoperability all over the place -- get your pharmacy ready. They're practically here.

The summer months can be a time of increased activity for many people, as warmer temperatures usher in numerous outdoor events that can be more strenuous and bring us closer to nature.

Glycopyrrolate bromide is a quick-onset long-acting muscarinic antagonist bronchodilator with FDA approval for use as maintenance treatment of COPD. Seebri Neohaler is approved for use at a dose of 15.6 ug inhaled twice daily.

There is a growing group of LAMA/LABA combination therapies in development. Investigations into the risks and benefits of LAMA/LABA therapy have demonstrated benefits.

Five pharmacies from four states have filed a class-action lawsuit against pharmacy benefit manager Express Scripts.

How do independent pharmacies survive? The best way to find out is to ask them.

A group of California pharmacists has sued CVS Health, accusing the retail giant of unfair business practices.

In one of the largest opioid diversion schemes to be uncovered in New York, a former pharmacy owner and her husband have pled guilty to several charges related to a multimillion-dollar oxycodone distribution scheme.

A new analysis found that Americans are misusing drugs–both illicit and prescribed drugs– at an alarming rate.

Medication reconciliation programs for patients discharged from hospitals reduced the risk of hospital readmission by 50% and helped avoid unnecessary health care costs, according to a new study.

Earlier this month, the city of Cambridge, Mass. honored retired pharmacist Emory J. “Doc” Clark by renaming a street corner after him.

So far, not many pharmacists are taking advantage of the opportunity.

Earlier this month, the U.S. Department of Justice announced that Rodney Dalton Logan, 63, of Muscle Shoals, Ala. agreed to plead guilty to obstructing a Medicare audit in 2012.

New branded drugs, new generics

New OTC products for eyes and ears.

There are so many opportunities for pharmacists out there. Technology can help uncover them, and we can follow them to a fulfilling career.

Medicare should have the same authority that Medicaid has to negotiate drug prices directly with manufacturers. If the government can do it for one program, it can do it for another.